Healthcare & Life Sciences
Seahorse Bioscience
United States
acquiredacquired
acquired
Stage
1
Investors
About
Seahorse Bioscience developed instruments and assay kits to measure cell metabolism and bioenergetics, facilitating research into neurodegeneration, aging, cancer, cardiovascular disease, and other biological processes. The company was acquired by Agilent Technologies in 2015.
Explore Seahorse Bioscience's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.